Therma Bright Inc. (TBRID)

Market Cap	2.89M
Revenue (ttm)	22.16K
Net Income (ttm)	-2.16M
Shares Out	n/a
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,450
Average Volume	5,969
Open	0.0524
Previous Close	0.0515
Day's Range	0.0500 - 0.0524
52-Week Range	0.0425 - 0.5968
Beta	n/a
RSI	43.06
Earnings Date	Nov 28, 2025

About CTI BioPharma

Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. The company’s products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk of burning the skin; Benepod, a hot and cold contrast therapy device for pain relief without pain relieving medication; V...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: TBRID

Financial Performance

In 2024, Therma Bright's revenue was 6,015, an increase of 192.56% compared to the previous year's 2,056. Losses were -2.45 million, -34.94% less than in 2023.